longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ARCT

ARCT
----

LongbridgeAI

The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021

Wallstreetcn
Oct 1, 2025 at 02:12 PM

Component stocks Applied Therapeutics rose 20.66%, Larimar Therapeutics Inc. rose 13.16%, Arcturus Therapeutics Holdings Inc. rose 10.47%, Abcellera Biologics rose 10.31%, and Design Therapeutics rose 9.93% ranking fifth. Astrazeneca ADR rose 6.6%, Regeneron Pharma rose 6.6%, and Moderna rose 6.4% performing well.

uniQure NV fell 5.14% ranking third from the bottom, Design Therapeutics fell 5.64%, and Enanta Pharmaceuticals also fell 13.78%

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
  • Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
  • Nov 11, 2025 at 01:51 PMConsolidating its position as the "largest heavyweight stock" in the UK market, pharmaceutical giant Astrazeneca's stock…
  • Jul 29, 2025 at 07:44 AMStrong sales of anti-cancer drugs, AstraZeneca's Q2 revenue increased by 12% year-on-year, exceeding expectations | Fina…

Related Stocks

Regeneron Pharma

Regeneron Pharma

USREGN

-0.58%

Arcturus Therapeutics

Arcturus Therapeutics

USARCT

-5.32%

Applied Therapeutics

Applied Therapeutics

USAPLT

0.00%